2025 Q2 -tulosraportti
142 päivää sitten37 min
Tarjoustasot
Oslo Børs
Määrä
Osto
9 259
Myynti
Määrä
137 786
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 1 | - | - | ||
| 7 878 | - | - | ||
| 1 456 | - | - | ||
| 28 534 | - | - | ||
| 5 297 | - | - |
Ylin
1,07VWAP
Alin
0,987VaihtoMäärä
2,4 2 372 920
VWAP
Ylin
1,07Alin
0,987VaihtoMäärä
2,4 2 372 920
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
| 2026 Q2 -tulosraportti | 20.8. |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q2 -tulosraportti | 28.8.2025 | |
| 2024 Q4 -tulosraportti | 10.4.2025 | |
| 2024 Q2 -tulosraportti | 29.8.2024 | |
| 2023 Q4 -tulosraportti | 25.4.2024 | |
| 2023 Q3 -tulosraportti | 9.11.2023 |
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·7 t sittenEmbarrassing to ask but don't have the energy to read all posts to get 🙂 of my approx 68000 shares I have received approx 23000 TR which are already under my holdings but tiø 0.15 kr ?? skalljakke this is paid before it gets there, see and I can tekne even more...no now I haven't been paying attention in class 🙂
·5 t sittenThe shell jacket (options) should be exercised so that you hedge against rain via warrants. But don't forget that the shell jacket protects the most important thing; namely the down jacket which constitutes your original holding.- ·11 t sitten
·5 t sitten · MuokattuSo, there will probably be a pump article on investornytt afterwards. Perhaps one should front-run with some heavy purchases before 0915 monday. - ·14 t sittenNow, the lack of insider buying can no longer be used against Circio. More such announcements will come as the entire management/board invests in this emission. A clearer "message" is hard to find.
·12 t sittenI don't understand what sellers are thinking... it's a strange psychology that the price MUST go below the issue price! But have traded accordingly and believe that in a few months we will see a market cap over 50m USD, i.e. 500 mill 👍🏻☺️ if you look at what other agreements and purchases are at, one becomes a bit strange in the head trying to calculate the price here 😅 Buy, hold, use subscription rights 🤠👍🏻 - ·16 t sitten · MuokattuNo one can guarantee anything in listed stocks. What one knows is that Circio has made significant progress in its technology development with several results, they underpin each other and reveal the potential of circVec. A number of collaboration projects with external parties testing the technology, a paid study from big pharma, all help to substantiate that there is substance in the technology they have developed over the last 3 years. Large amounts have been invested. Furthermore, we now know that a financial basis for further developing circVec is guaranteed. The assessment is whether this justifies an mcap of 2 -250.mill including the capital that is now coming in. What is the risk compared to the possible reward in the next 12 months? My opinion is that it will take little in terms of new good results or agreements before one will see a completely different mcap for Circio. As a shareholder, one just has to live through these 14 emission days. Circio's emission cannot be compared with most others that one has seen in recent years. I do not want to be out of this stock for the next six months.·14 t sitten · MuokattuI'm not a bio expert, but after having been in and out of various such bio stocks in recent years, it is my personal opinion that this is the biotech stock on the exchange here that has the most potential and best risk/reward. The entry price and mcap are still low, the technology has enormous potential in many treatments and areas, the risk is lower as it will not primarily run its own long-term studies with win-or-lose outcomes. The risk is spread across many areas. And now the financing is finally in place.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q2 -tulosraportti
142 päivää sitten37 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·7 t sittenEmbarrassing to ask but don't have the energy to read all posts to get 🙂 of my approx 68000 shares I have received approx 23000 TR which are already under my holdings but tiø 0.15 kr ?? skalljakke this is paid before it gets there, see and I can tekne even more...no now I haven't been paying attention in class 🙂·5 t sittenThe shell jacket (options) should be exercised so that you hedge against rain via warrants. But don't forget that the shell jacket protects the most important thing; namely the down jacket which constitutes your original holding.
- ·11 t sitten·5 t sitten · MuokattuSo, there will probably be a pump article on investornytt afterwards. Perhaps one should front-run with some heavy purchases before 0915 monday.
- ·14 t sittenNow, the lack of insider buying can no longer be used against Circio. More such announcements will come as the entire management/board invests in this emission. A clearer "message" is hard to find.·12 t sittenI don't understand what sellers are thinking... it's a strange psychology that the price MUST go below the issue price! But have traded accordingly and believe that in a few months we will see a market cap over 50m USD, i.e. 500 mill 👍🏻☺️ if you look at what other agreements and purchases are at, one becomes a bit strange in the head trying to calculate the price here 😅 Buy, hold, use subscription rights 🤠👍🏻
- ·16 t sitten · MuokattuNo one can guarantee anything in listed stocks. What one knows is that Circio has made significant progress in its technology development with several results, they underpin each other and reveal the potential of circVec. A number of collaboration projects with external parties testing the technology, a paid study from big pharma, all help to substantiate that there is substance in the technology they have developed over the last 3 years. Large amounts have been invested. Furthermore, we now know that a financial basis for further developing circVec is guaranteed. The assessment is whether this justifies an mcap of 2 -250.mill including the capital that is now coming in. What is the risk compared to the possible reward in the next 12 months? My opinion is that it will take little in terms of new good results or agreements before one will see a completely different mcap for Circio. As a shareholder, one just has to live through these 14 emission days. Circio's emission cannot be compared with most others that one has seen in recent years. I do not want to be out of this stock for the next six months.·14 t sitten · MuokattuI'm not a bio expert, but after having been in and out of various such bio stocks in recent years, it is my personal opinion that this is the biotech stock on the exchange here that has the most potential and best risk/reward. The entry price and mcap are still low, the technology has enormous potential in many treatments and areas, the risk is lower as it will not primarily run its own long-term studies with win-or-lose outcomes. The risk is spread across many areas. And now the financing is finally in place.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Oslo Børs
Määrä
Osto
9 259
Myynti
Määrä
137 786
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 1 | - | - | ||
| 7 878 | - | - | ||
| 1 456 | - | - | ||
| 28 534 | - | - | ||
| 5 297 | - | - |
Ylin
1,07VWAP
Alin
0,987VaihtoMäärä
2,4 2 372 920
VWAP
Ylin
1,07Alin
0,987VaihtoMäärä
2,4 2 372 920
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
| 2026 Q2 -tulosraportti | 20.8. |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q2 -tulosraportti | 28.8.2025 | |
| 2024 Q4 -tulosraportti | 10.4.2025 | |
| 2024 Q2 -tulosraportti | 29.8.2024 | |
| 2023 Q4 -tulosraportti | 25.4.2024 | |
| 2023 Q3 -tulosraportti | 9.11.2023 |
2025 Q2 -tulosraportti
142 päivää sitten37 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
| 2026 Q2 -tulosraportti | 20.8. |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q2 -tulosraportti | 28.8.2025 | |
| 2024 Q4 -tulosraportti | 10.4.2025 | |
| 2024 Q2 -tulosraportti | 29.8.2024 | |
| 2023 Q4 -tulosraportti | 25.4.2024 | |
| 2023 Q3 -tulosraportti | 9.11.2023 |
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·7 t sittenEmbarrassing to ask but don't have the energy to read all posts to get 🙂 of my approx 68000 shares I have received approx 23000 TR which are already under my holdings but tiø 0.15 kr ?? skalljakke this is paid before it gets there, see and I can tekne even more...no now I haven't been paying attention in class 🙂·5 t sittenThe shell jacket (options) should be exercised so that you hedge against rain via warrants. But don't forget that the shell jacket protects the most important thing; namely the down jacket which constitutes your original holding.
- ·11 t sitten·5 t sitten · MuokattuSo, there will probably be a pump article on investornytt afterwards. Perhaps one should front-run with some heavy purchases before 0915 monday.
- ·14 t sittenNow, the lack of insider buying can no longer be used against Circio. More such announcements will come as the entire management/board invests in this emission. A clearer "message" is hard to find.·12 t sittenI don't understand what sellers are thinking... it's a strange psychology that the price MUST go below the issue price! But have traded accordingly and believe that in a few months we will see a market cap over 50m USD, i.e. 500 mill 👍🏻☺️ if you look at what other agreements and purchases are at, one becomes a bit strange in the head trying to calculate the price here 😅 Buy, hold, use subscription rights 🤠👍🏻
- ·16 t sitten · MuokattuNo one can guarantee anything in listed stocks. What one knows is that Circio has made significant progress in its technology development with several results, they underpin each other and reveal the potential of circVec. A number of collaboration projects with external parties testing the technology, a paid study from big pharma, all help to substantiate that there is substance in the technology they have developed over the last 3 years. Large amounts have been invested. Furthermore, we now know that a financial basis for further developing circVec is guaranteed. The assessment is whether this justifies an mcap of 2 -250.mill including the capital that is now coming in. What is the risk compared to the possible reward in the next 12 months? My opinion is that it will take little in terms of new good results or agreements before one will see a completely different mcap for Circio. As a shareholder, one just has to live through these 14 emission days. Circio's emission cannot be compared with most others that one has seen in recent years. I do not want to be out of this stock for the next six months.·14 t sitten · MuokattuI'm not a bio expert, but after having been in and out of various such bio stocks in recent years, it is my personal opinion that this is the biotech stock on the exchange here that has the most potential and best risk/reward. The entry price and mcap are still low, the technology has enormous potential in many treatments and areas, the risk is lower as it will not primarily run its own long-term studies with win-or-lose outcomes. The risk is spread across many areas. And now the financing is finally in place.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Oslo Børs
Määrä
Osto
9 259
Myynti
Määrä
137 786
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 1 | - | - | ||
| 7 878 | - | - | ||
| 1 456 | - | - | ||
| 28 534 | - | - | ||
| 5 297 | - | - |
Ylin
1,07VWAP
Alin
0,987VaihtoMäärä
2,4 2 372 920
VWAP
Ylin
1,07Alin
0,987VaihtoMäärä
2,4 2 372 920
Välittäjätilasto
Dataa ei löytynyt